Dépôt numérique
RECHERCHER

Very-long-chain fatty acid metabolic capacity of 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) promotes replication of hepatitis C virus and related flaviviruses

Téléchargements

Téléchargements par mois depuis la dernière année

Plus de statistiques...

Mohamed, Bassim, Mazeaud, Clément, Baril, Martin, Poirier, Donald, Sow, Aïssatou Aïcha, Chatel-Chaix, Laurent ORCID: https://orcid.org/0000-0002-7390-8250, Titorenko, Vladimir I et Lamarre, Daniel (2020). Very-long-chain fatty acid metabolic capacity of 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) promotes replication of hepatitis C virus and related flaviviruses Scientific Reports , vol. 10 , nº 4040. p. 1-15. DOI: 0.1038/s41598-020-61051-w.

[thumbnail of Very-long-chain fatty acid metabolic capacity of 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) promotes replication of hepatitis C virus and related flaviviruses-chatel cahix 2020.pdf]
Prévisualisation
PDF - Version publiée
Disponible sous licence Creative Commons Attribution.

Télécharger (2MB) | Prévisualisation

Résumé

Flaviviridae infections represent a major global health burden. By deciphering mechanistic aspects of hepatitis C virus (HCV)-host interactions, one could discover common strategy for inhibiting the replication of related flaviviruses. By elucidating the HCV interactome, we identified the 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) as a human hub of the very-long-chain fatty acid (VLCFA) synthesis pathway and core interactor. Here we show that HSD17B12 knockdown (KD) impairs HCV replication and reduces virion production. Mechanistically, depletion of HSD17B12 induces alterations in VLCFA-containing lipid species and a drastic reduction of lipid droplets (LDs) that play a critical role in virus assembly. Oleic acid supplementation rescues viral RNA replication and production of infectious particles in HSD17B12 depleted cells, supporting a specific role of VLCFA in HCV life cycle. Furthermore, the small-molecule HSD17B12 inhibitor, INH-12, significantly reduces replication and infectious particle production of HCV as well as dengue virus and Zika virus revealing a conserved requirement across Flaviviridae virus family. Overall, the data provide a strong rationale for the advanced evaluation of HSD17B12 inhibition as a promising broad-spectrum antiviral strategy for the treatment of Flaviviridae infections.

Type de document: Article
Mots-clés libres: Microbiology; Hepatitis C virus
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 20 juill. 2021 04:18
Dernière modification: 15 févr. 2022 14:05
URI: https://espace.inrs.ca/id/eprint/11642

Actions (Identification requise)

Modifier la notice Modifier la notice